Profound Medical Corp. (PROF) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Profound Medical Corp. (PROF) closed at USD 6.62 on 2026-10-14, a change of +6.8 % over the past year, with a market capitalization of USD 230.52M.

Profound Medical Corp. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Profound Medical Corp. key figures

Previous close

USD 6.62 (2026-10-14)

1-year change

+6.8 %

Market cap

USD 230.52M

Enterprise value

USD 199.63M

P/E ratio (trailing)

-7.09

P/E ratio (forward)

-10.73

EPS (trailing)

-0.89

EPS (forward)

-0.59

PEG ratio

n/a

Price to book

4.63

Revenue growth

12.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

11.80

Employees

162

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Profound Medical Corp.

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Profound Medical Corp. and compare it with other stocks.